| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.27B | -2.7% |
| Cost of Revenue | $5.55B | +1.1% |
| Gross Profit | $6.72B | -5.7% |
| R&D Expense | $2.36B | +0.6% |
| SG&A Expense | $1.20B | +3.4% |
| Operating Income | $3.05B | -10.8% |
| Interest Expense | $466.0M | +17.1% |
| Pre-tax Income | $2.66B | -14.1% |
| Income Tax | $525.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.27B | -0.8% |
| Accounts Receivable | $1.05B | +2.2% |
| Inventory | $2.58B | +9.4% |
| Current Assets | $7.94B | +8.7% |
| Total Assets | $26.56B | +8.9% |
| Current Liabilities | $3.88B | +25.3% |
| Long-term Debt | $11.04B | +6.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.82B | +1.4% |
| Capital Expenditures | $397.0M | -45.4% |
| Investing Cash Flow | -$2.36B | -243.6% |
| Financing Cash Flow | -$494.0M | +81.4% |
| Free Cash Flow | $2.42B | +17.9% |
| -3.7% |
| Net Income | $2.02B | -19.5% |
| EPS (Basic) | $8.00 | -18.7% |
| EPS (Diluted) | $7.95 | -18.3% |
| Stockholders' Equity |
| $10.06B |
| +9.5% |